Create your Personal Health Record and unlock support built around you

Aligned with your diagnosis, treatment and where you are in your care. It lets HealthTree show you:

Treatments and trials you qualify for
Education for your stage of care
Financial support for your medications
Solutions to your side effects

Learn more about HealthTree

Lymphoma CAR T-cell Therapy Guide image

Lymphoma CAR T-cell Therapy Guide

Posted by

HealthTree

Last updated and reviewed on: December 10, 2025

This guide is meant to help people with lymphoma and their loved ones learn about chimeric antigen receptor (CAR) T-cell therapies.

See content from

Introduction

In this section, you will learn about the purpose of this guide and how to navigate it.

How CAR T-cell Therapy Works

In this section of the guide, learn how CAR T-cell therapy for lymphoma works.

What Surface Protein Do CAR T-cell Therapies Target in Lymphoma?

Learn about the surface proteins that lymphoma CAR T-cell therapies target.

What’s the Difference Between CAR T-cell Therapy and a Stem Cell Transplant?

Learn about the difference between CAR T-cell therapy and a stem cell transplant.

When to Consider CAR-T Cell Therapy?

Learn factors that doctors consider when recommending CAR T-cell therapy for people with lymphoma.

Who is Eligible for CAR-T?

Learn which people with lymphoma are eligible for CAR T-cell therapy.

Front‑Line CAR‑T Clinical Trials

Learn about clinical trials that test CAR-T as an earlier treatment option for lymphoma.

What to Consider Before CAR T-cell Therapy

Learn what to consider before CAR T-cell therapy for lymphoma.

CAR T-cell Therapy: Benefits and Barriers

Learn about the benefits and barriers to CAR T-cell therapy for lymphoma.

FDA-Approved Lymphoma CAR T-cell Therapies

Learn about the FDA-approved CAR T-cell therapies for people with lymphoma.

CAR-T for Follicular Lymphoma

Learn about the FDA-approved CAR T-cell therapies for people with follicular lymphoma.

CAR-T for Large B-cell Lymphoma (LBCL)

Learn about the FDA-approved CAR T-cell therapies for people with large B-cell lymphoma (LBCL).

CAR-T for Mantle Cell Lymphoma (MCL)

Learn about the FDA-approved CAR T-cell therapies for people with mantle cell lymphoma (MCL).

CAR-T for Marginal Zone Lymphoma (MZL)

Learn about the FDA-approved CAR T-cell therapies for people with marginal zone lymphoma (MZL).

CAR-T for Small Lymphocytic Lymphoma (SLL)

Learn about the FDA-approved CAR T-cell therapy for small lymphocytic lymphoma (SLL)/chronic lymphocytic leukemia (CLL).

Side Effect Management of CAR T-cell Therapy for Lymphoma

Learn why common side effects of CAR T-cell therapy happen and how they are managed for people with lymphoma.

Cytokine Release Syndrome (CRS)

Learn why cytokine release syndrome (CRS) happens from CAR T-cell therapy and how it is managed.

Neurotoxicity and ICANS

Learn what neurotoxicity and ICANS are, why they sometimes happen from CAR T-cell therapy for lymphoma, and how they are managed.

Low Blood Counts

Learn why low blood counts happen from CAR T-cell therapy for lymphoma and how they are managed.

Infections

Learn why infections happen after CAR T-cell therapy for lymphoma and how they are managed.

Digestive Side Effects

Learn about the digestive or gastrointestinal (GI) side effects of CAR T-cell therapy for lymphoma and how they are managed.

Fatigue

Learn why fatigue happens after CAR T-cell therapy for lymphoma and how to manage it.

Muscle, Joint, and Bone Pain

Learn why muscle, joint, and bone pain happen after CAR T-cell therapy for lymphoma and how to manage them.

The Future of CAR-T for Lymphoma

Learn about newer types of CAR T-cell therapies for lymphoma in clinical trials.

Caregiver Role in Lymphoma CAR-T

Helping your loved one prepare for and recover from CAR T-cell therapy can be challenging. This section outlines ways the patient may need support and offers tips to help you in your role as their care partner.

How to Support A Person with Lymphoma Receiving CAR T-cell Therapy

Learn how your loved one with lymphoma may need help from a care partner during CAR-T therapy. Knowing what to expect can help you feel more prepared for the role.

Supportive Measures for Caregivers

Caring for someone receiving CAR T-cell therapy can be demanding. Learn strategies to help care partners stay healthy while supporting their loved one.

What If I Don’t Have a Caregiver for CAR T-Cell Therapy?

Many people wonder if they can still receive CAR T-cell therapy without a full-time caregiver. The good news is that there are solutions, and not having a caregiver does not automatically disqualify you from treatment.

Communicating with Your Healthcare Team

This section helps you understand how to talk with your healthcare team about chimeric antigen receptor (CAR) T-cell therapy for lymphoma. You’ll learn what questions to ask, what to expect, and how to make informed decisions about this treatment.

When to Ask About CAR T-cell Therapy

Knowing when to bring up CAR T-cell therapy as a treatment option can help ensure it's discussed at the right time.

What to Ask Your Doctor

Discover questions you can ask your doctor about CAR T-cell therapy for lymphoma.

Involving Care Partners in the Conversation

Sometimes, going to a healthcare appointment alone can feel overwhelming. Having a loved one come with you can help carry some of the weight when addressing all concerns and questions.

When to Get a Second Opinion?

Getting another expert’s perspective can offer peace of mind and ensure you’re making the most informed decision for your unique situation.

Keep Track of What You Learn

When discussing complex treatments like CAR T-cell therapy, it’s easy to feel overwhelmed. Staying organized helps you make decisions with more confidence and clarity.

Keeping Your Care Team Informed

Open communication with your care team is essential, especially when navigating complex treatments like CAR T-cell therapy. If you have questions, concerns, or if something doesn’t feel right, don’t hesitate to speak up.

Transferring Your Care to Your Clinic

If you’re considering transferring to a different health care team or center, learn about the steps you need to take.

Coming Home and Follow-up Appointments

Recovery after CAR T-cell therapy for lymphoma takes time as your immune system slowly rebuilds. The first 30 days after the infusion are considered the acute recovery period.

Ongoing Monitoring, Medications, and Life After Treatment

For the first month after the CAR-T infusion, you will have at least weekly appointments to check blood counts and manage any side effects.

Financial Resources for Lymphoma CAR-T

People with lymphoma often report that finances are one of the biggest concerns for CAR T-cell therapy. Discover financial resources that may help you manage CAR-T costs.

Understanding Medicare Coverage for Lymphoma CAR-T

Learn how medicare coverage works for lymphoma CAR T-cell therapies.

Pharmaceutical Company CAR-T Assistance Programs

Learn about pharmaceutical company assistance programs for lymphoma CAR T-cell therapies.

Explore Additional Financial Resources

Explore additional financial resources for lymphoma CAR T-cell therapy.

Additional Resources

This section contains additional resources that might be helpful as you learn more about CAR T-cell therapy for lymphoma.

HealthTree Resources

We invite you to read the sources below to learn more about CAR T-cell therapy for lymphoma.

External Resources

This resource list also acts as a reference for this guide, as much of the material referenced was used to create the content.

Related Content